Skip to main content
Signal8
Agrawal Sundeep profile photo

Sundeep Agrawal

CIK: 0001840599

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (83.3%)

Compensation grants

Other (G, F, J, C, D, …)1 (16.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

BlossomHill Therapeutics, Inc. logo
BLSM

BlossomHill Therapeutics, Inc.

Director
PAVmed Inc. logo
PAVM

PAVmed Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • BlossomHill Therapeutics, Inc. logo
    BLSM

    BlossomHill Therapeutics, Inc.

    Aug 10, 2026
    Conversion(C)
    Indirect
    578.5K shares-
  • BlossomHill Therapeutics, Inc. logo
    BLSM

    BlossomHill Therapeutics, Inc.

    Aug 6, 2026
    Award(A)

    Director Stock Option (Right to Buy)

    Direct
    23.9K shares-
  • PAVmed Inc. logo
    PAVM

    PAVmed Inc.

    Apr 2, 2026
    Award(A)
    Direct
    13.9K shares-
  • PAVmed Inc. logo
    PAVM

    PAVmed Inc.

    Sep 30, 2025
    Award(A)
    Direct
    150K shares-
  • PAVmed Inc. logo
    PAVM

    PAVmed Inc.

    Oct 21, 2024
    Award(A)

    Employee stock option (right to buy)

    Direct
    50K shares-
  • PAVmed Inc. logo
    PAVM

    PAVmed Inc.

    Sep 19, 2024
    Award(A)

    Employee stock option (right to buy)

    Direct
    205K shares-

1-6 of 6

About Agrawal Sundeep

Agrawal Sundeep (SEC CIK 0001840599) files insider reports with the SEC as Director of BlossomHill Therapeutics, Inc. (BLSM) and Director of PAVmed Inc. (PAVM).

Signal8 holds 7 ownership filings by Agrawal Sundeep (2 Form 3, 5 Form 4), filed between Sep 20, 2024 and Aug 10, 2026. Those filings report 6 transactions, from Sep 19, 2024 to Aug 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Agrawal Sundeep's filings is in SAN DIEGO, CA.

Recent filings by Agrawal Sundeep

  • Aug 10, 2026: Conversion of BLSM shares (Form 4, code C).
  • Aug 6, 2026: Grant or award of BLSM derivative securities (Form 4, code A).
  • Apr 2, 2026: Grant or award of PAVM shares (Form 4, code A).
  • Sep 30, 2025: Grant or award of PAVM shares (Form 4, code A).
  • Oct 21, 2024: Grant or award of PAVM derivative securities (Form 4, code A).

Other insiders filing for BlossomHill Therapeutics, Inc. (BLSM)

How to read Form 4 transaction codes